The stock of Absolute Software (TSE:ABT) is a huge mover today! About 80,323 shares traded hands or 44.99% up from the average. Absolute Software (TSE:ABT) has declined 9.12% since March 10, 2016 and is downtrending. It has underperformed by 14.73% the S&P500.
The move comes after 5 months negative chart setup for the $239.71 million company. It was reported on Oct, 17 by Barchart.com. We have $5.67 PT which if reached, will make TSE:ABT worth $23.97 million less.
Absolute Software (TSE:ABT) Ratings Coverage
Out of 6 analysts covering Absolute Software (TSE:ABT), 2 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 33% are positive. $10.50 is the highest target while $8 is the lowest. The $9.25 average target is 46.83% above today’s ($6.3) stock price. Absolute Software has been the topic of 10 analyst reports since August 19, 2015 according to StockzIntelligence Inc. The stock has “Market Perform” rating given by Cormark Securities on Wednesday, May 11. The firm has “Sector Perform” rating given on Monday, August 22 by Scotia Capital. Canaccord Genuity initiated the stock with “Buy” rating in Thursday, October 22 report.
More recent Absolute Software (TSE:ABT) news were published by: Reuters.com which released: “BRIEF-Absolute Software announces approval of normal course issuer bid” on August 24, 2016. Also Seekingalpha.com published the news titled: “Absolute Software’s (ALSWF) CEO Geoff Haydon on F4Q 2016 Results – Earnings …” on August 19, 2016. Bloomberg.com‘s news article titled: “TSX Movers: Bombardier, Valeant, Absolute Software” with publication date: August 22, 2016 was also an interesting one.
Absolute Software Corporation is engaged in the development, marketing and support of endpoint security and data risk management solutions to commercial, healthcare, education and government customers. The company has a market cap of $239.71 million. The Firm operates through Data and Device Security segment. It has a 19.9 P/E ratio. The Firm offers solutions for devices, such as computers, laptops, tablets and smartphones.
ABT Company Profile
Abbott Laboratories (Abbott), incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Firm operates in four business divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Nutrition Products segment includes the sales of a line of adult and pediatric nutritional products. The Diagnostic Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.